Skip to Content
News

Akadeum Life Sciences Announces New Dead Cell Removal Kit Using Microbubble Technology

Published on Aug 25, 2022

This new buoyant separation method creates a more effective way for researchers to use valuable samples with a higher retention rate of viable cells than current magnetic techniques

Ann Arbor, MI – August 4, 2022 – Akadeum Life Sciences, Inc.—a global leader in buoyancy-based technology in cell therapy manufacturing, clinical diagnostics, and cell and molecular research for human health and life sciences—announces today the launch of their Dead Cell Removal Microbubble Kit (“DCR kit”). This kit enables researchers to separate viable cells from dead cells, resulting in the elimination of the detrimental effects of these dead cells on transfection protocols, cell culture experiments, functional studies or single cell applications.

Akadeum’s DCR kit uses microbubbles, which offer researchers a more simplified and less cumbersome experience than conventional techniques by removing the need for costly and less-effective materials such as cartridges, magnetic columns or stand-alone instruments. When mixed in the sample, the microbubbles bind to the dead cells and then float them to the surface for removal, leaving behind a clean sample full of healthy cells.

“We have embraced the challenge of developing products that can meet the needs of researchers and address obstacles they currently face,” says Brandon McNaughton, PhD, CEO of Akadeum. “We believe our DCR kit will help researchers get to the results they seek efficiently and effectively.”

This revolutionary cell separation method is unlike other DCR kits because it effectively maintains a larger number of viable cells while removing the dead cells in a sample. In recent studies, Akadeum was able to retain over 85% of viable cells as compared to 20-40% from traditional DCR methods that use magnetic techniques. Additionally, Akadeum’s kit only requires about half the starting amount of cells as other methods due to its low rate of cell loss.

The benefits from the microbubble technology are vital for researchers, giving them more flexibility in types and numbers of experiments that can be performed. The Akadeum DCR kit was developed to meet the needs of researchers by providing them with more testable samples and time, improving the likelihood that they obtain the best possible results.

For more information, visit https://www.akadeum.com.

About Akadeum Life Sciences, Inc.

Akadeum Life Sciences was formed to solve longstanding sample preparation problems in research, diagnostics, and cell therapy markets with a novel floatation-based target isolation platform technology. Without the critical step of separation (isolating biological targets like DNA, proteins, or cells from biological samples), many diagnostics and therapies would not be possible. More than a solution to a single problem, this elegantly simple platform technology is disrupting the separation market—from nucleic acid extraction to cell isolation. The company was the first to commercialize Buoyancy Activated Cell Sorting (BACS™) microbubble kits for cell isolation applications. In parallel, the company is also establishing industry partnerships.

To learn more about Ann Arbor, MI-based Akadeum and its products, visit https://www.akadeum.com.

Inquiries into Akadeum’s products, technology, or partnership opportunities can be made at info@akadeum.com.

Media Contact

media@akadeum.com

Uproar PR for Akadeum

Erin Robertson Davila

erobertson@uproarpr.com

(904) 716-4439

Back to Top